Genitors of the Pacific oyster Crassostrea gigas were submitted during gametogenesis to a short pulse exposure to the herbicide diuron at a realistic environmental concentration. Histological analysis showed no effect of diuron on gametogenesis course, sex ratio and reproductive effort. A non-significant increase in testosterone and progesterone levels was observed in genitors exposed to the herbicide. At cell level, diuron exposure was shown to modulate the phagocytic activity of circulating hemocytes. The results of a transcriptional analysis showed that diuron affected the expression of genes belonging to functions known to play a major role during oyster gametogenesis such as gene transcription regulation, DNA replication and repair, DNA methylation and cytokinesis. Taking into account the results we previously obtained on the same genitors, this study showed a negative effect of diuron on oyster reproduction by inducing both structural and functional modifications of the DNA.
Arctic sea routes are opening up for maritime transport due to sea ice retreat leading to increasing human activities in the Arctic and concomitant pressures on the environment. Organotin compounds are used in antifouling paints of large seagoing vessels and are known to leach into the marine environment and accumulate in sediments and biota. As organotin levels in Svalbard sediments have not been documented in peer-reviewed literature before, this study describes the levels in sediment of harbours around Svalbard (Ny-Å lesund, Longyearbyen, Svea, Pyramiden and Barentsburg). Organotin levels in sediments of Svalbard harbours were low (below the detection limit up to 14 ng Sn/g dw sum-butyltin) compared to other Arctic regions with a longer history of shipping. Levels were below known no effect levels and in accordance, no imposex was found in marine whelks from Ny-Å lesund harbour. Of all other analysed compounds in sediments of Kongsfjorden (polycyclic aromatic hydrocarbon (PAHs), polychlorinated biphenyls, polybrominated diphenylethers and perfluorinated compounds) PAH levels were highest and in one sample above action levels. It is advised to continue monitoring contaminant levels, for which the current results form a good basis. If contaminant levels rise, mitigation measures can be taken in time.
Monitoring parameters for the assessment of oil and gas related contaminants and their biological effects need validation before application in the Arctic. For such monitoring purposes, we evaluated the potential use of three biomarkers (acetylcholinesterase, acyl-CoA oxidase and glutathione S-transferase) for application to an Arctic bivalve (Astarte borealis) and determined the body residue of pyrene and two pyrene metabolites (1-hydroxypyrene and pyrene-1-glucuronide) in Arctic benthic species (bivalve: Macoma calcarea; polychaete:Nephtys ciliata) and temperate benthic species (bivalve: Limecola balthica; polychaete: Alitta virens) in order to establish the potential of polycyclic aromatic hydrocarbons (PAHs) metabolite profiles as biomarkers of exposure in such species. Experimental PAH exposure levels were probably too low (0.2 -1.7 mg/kg dry weight in sediment) to induce or inhibit biomarker responses in A. borealis. Concentrations of pyrene and pyrene metabolites varied between species, although no consistent patterns could be established among taxonomic groups and locations. Metabolites made up to 79% of the total pyrene concentrations, indicating that basal metabolic activity is affecting pyrene kinetics even at low concentrations in all species. This indicates that Arctic and temperate species could show similar metabolism patterns of PAHs, although more insight into the effects of confounding factors is needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.